154 related articles for article (PubMed ID: 29996342)
1. [Diagnostic imaging of primary hepatic neuroendocrine tumors and treatment with transarterial chemoembolization: analysis of 6 cases].
Li XS; Zhang MC; Qu YC; Zhang XQ; Pan F; Liu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):294-297. PubMed ID: 29996342
[No Abstract] [Full Text] [Related]
2. Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Primary Neuroendocrine Tumors of the Liver.
Han Y; Li L; Sun H
World Neurosurg; 2020 Jun; 138():723-731. PubMed ID: 32006738
[TBL] [Abstract][Full Text] [Related]
3. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of primary hepatic neuroendocrine carcinoma].
Xu K; Chen Y; Chen M; Zhang W; Wang Y; Ji W; Wang H; Xin X; Feng J; Li Y; Yan L
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):451-5. PubMed ID: 26463150
[TBL] [Abstract][Full Text] [Related]
5. Experience in primary hepatic neuroendocrine tumor.
Jia C; Zhang Y; Xu J; Sun K
Turk J Gastroenterol; 2012; 23(5):546-51. PubMed ID: 23161300
[TBL] [Abstract][Full Text] [Related]
6. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.
Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
World J Gastroenterol; 2015 Mar; 21(10):3132-8. PubMed ID: 25780316
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review.
Xia Y; Zhang L; Wu H; Qiao L; Xia L
J Int Med Res; 2020 Jun; 48(6):300060520932114. PubMed ID: 32589085
[TBL] [Abstract][Full Text] [Related]
8. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
Hui TC; Pua U
J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
[TBL] [Abstract][Full Text] [Related]
9. Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation.
Tong YS; Huang TL; Chen TY; Tsang LLC; Ou HY; Yu CY; Hsu HW; Xiong LW; Liao CC; Eng HL; Chen CL; Cheng YF
Transplant Proc; 2018 Nov; 50(9):2622-2625. PubMed ID: 30401362
[TBL] [Abstract][Full Text] [Related]
10. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses.
Yalav O; Ülkü A; Akçam TA; Demiryürek H; Doran F
Turk J Gastroenterol; 2012 Jun; 23(3):272-8. PubMed ID: 22798119
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
[TBL] [Abstract][Full Text] [Related]
14. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations.
Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
Cancer Imaging; 2017 Jul; 17(1):20. PubMed ID: 28683830
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
Kono Y; Lucidarme O; Choi SH; Rose SC; Hassanein TI; Alpert E; Mattrey RF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):57-65. PubMed ID: 17296705
[TBL] [Abstract][Full Text] [Related]
16. Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.
Lam A; Fernando D; Sirlin CC; Nayyar M; Goodwin SC; Imagawa DK; Lall C
Clin Radiol; 2017 Nov; 72(11):994.e9-994.e16. PubMed ID: 28779950
[TBL] [Abstract][Full Text] [Related]
17. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.
Yang K; Zhang XM; Yang L; Xu H; Peng J
World J Gastroenterol; 2016 May; 22(20):4835-47. PubMed ID: 27239110
[TBL] [Abstract][Full Text] [Related]
18. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
[TBL] [Abstract][Full Text] [Related]
20. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
